Belite Bio, Inc Retained Earnings
Belite Bio, Inc (BLTE) had Retained Earnings of -$185.26 million as of 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-03-31
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$185.26M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$107.65M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$71.50M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$39.87M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-12-31 | -$185.26M 20-F · filed 2026-03-31 |
| 2024-12-31 | -$107.65M 20-F · filed 2026-03-31 |
| 2023-12-31 | -$71.50M 20-F · filed 2025-03-17 |
| 2022-12-31 | -$39.87M 20-F · filed 2024-03-12 |
| 2021-12-31 | -$27.22M 20-F · filed 2023-03-31 |
| 2020-12-31 | -$17.60M 20-F · filed 2023-03-31 |